TMCnet News

Research and Markets: Global Muscle Spasticity Pipeline Report 2015
[May 27, 2015]

Research and Markets: Global Muscle Spasticity Pipeline Report 2015


Research and Markets (http://www.researchandmarkets.com/research/wttr8q/muscle_spasticity) has announced the addition of the "Muscle Spasticity - Pipeline Review, H1 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Muscle Spasticity, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also revies key players involved in the therapeutic development for Muscle Spasticity and special features on late-stage and discontinued projects.



The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development


  • Daewoong Pharmaceutical Co., Ltd.
  • Ipsen S.A.
  • OBI Pharma, Inc.
  • Sanochemia Pharmazeutika AG
  • Sun Pharma Advanced Research Company Ltd.

Drug Profiles

  • abobotulinumtoxin A
  • baclofen ER
  • NB-2221
  • OBI-858
  • onabotulinumtoxin A
  • tolperisone

For more information visit http://www.researchandmarkets.com/research/wttr8q/muscle_spasticity


[ Back To TMCnet.com's Homepage ]